drugset / Trial / NCT06962956
Evaluating Gingivitis and Systemic Biomarkers
RandomizedParallel-groupDouble-blindBasic science
Summary
This exploratory study will consist of two parts: Phase 1 (sample collection/screening) and Phase 2 (sample collection/product efficacy testing). The purpose of Phase 1 is to understand the association of gingivitis to systemic biomarkers and to screen subjects for Phase 2. The purpose of Phase 2 is to assess the causal effect of oral hygiene intervention on gingivitis and systemic biomarkers.
Timeline
- Start
- 2025-04-30
- Primary completion
- 2025-10-31
- Completion
- 2025-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | sodium monofluorophosphate | Unknown | 0.76 % | — |
| Comparator | stannous fluoride | Small molecule | 0.454 % | — |